NCT06405295View on ClinicalTrials.gov

Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation

Enrolling by invitationOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

May 6, 2024

Primary Completion Date

March 1, 2029

Study Completion Date

May 1, 2029

Conditions
Breast CarcinomaBRCA MutationAdjuvant Drug Therapy
Interventions
OTHER

no intervention

Observation of the prognosis of patients with different standard treatment protocols in the clinic without intervention

Trial Locations (1)

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER